ArticleFrontiers in endocrinology2023

CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.

Kun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.